当前位置:首页 - 行情中心 - 康泰生物(300601) - 财务分析 - 利润表

康泰生物

(300601)

71.96

-0.63  (-0.87%)

今开:72.63最高:74.90成交:4.18万手 市盈:0.00 上证指数:3075.03   -1.38%2018-04-26
昨收:72.59 最低:71.16 换手:0.00%振幅:0.00 深证指数:10292.12  -2.42%15:02:03

集合

竞价

利润表

按照会计年度查询:
报告期2018-03-312017-12-312017-09-302017-06-30
一、营业总收入403,309,457.681,161,175,811.63794,381,859.19469,310,219.04
营业收入403,309,457.681,161,175,811.63794,381,859.19469,310,219.04
二、营业总成本280,004,841.87961,408,507.52639,890,612.11398,306,280.09
营业成本36,017,932.24136,334,892.1690,129,375.552,898,517.31
营业税金及附加1,738,364.887,010,733.294,667,201.013,008,853.45
销售费用197,359,003.92615,418,770.68410,247,048.13245,824,866.69
管理费用39,204,553.91181,929,145.41117,672,557.5480,133,831.5
财务费用2,439,916.322,024,413.941,500,720.831,565,044.56
资产减值损失3,245,070.618,690,552.0415,673,709.114,875,166.58
三、其他经营收益--------
允许价值变动净收益--------
投资净收益1,179,166.581,880,029.83709,921.57644,759.44
联营、合营企业投资收益--------
汇兑净收益--------
四、营业利润125,673,966.45242,161,710.46155,201,168.6571,648,698.39
营业外收入3,955,775.09857,424.0627,086,511.88,121,142.59
营业外支出33,346.255,034,500.571,513,010.191,369,123.68
非流动资产处置净损失----1,224,505.781,182,494.79
五、利润总额129,596,395.29237,984,633.95180,774,670.2678,400,717.3
所得税19,716,998.0123,281,151.3124,414,207.797,853,964.2
未确认的投资损失--------
六、净利润(百万元)109.88214.7156.3670.55
少数股东损益--------
归属于母公司股东的净利润109,879,397.28214,703,482.64156,360,462.4770,546,753.1
七、每股收益0.270.530.380.17
基本每股收益0.270.530.380.17
稀释每股收益0.270.530.380.17
TOP↑